Skip to main content
. Author manuscript; available in PMC: 2011 Sep 21.
Published in final edited form as: Congenit Heart Dis. 2011 Jan-Feb;6(1):9–17. doi: 10.1111/j.1747-0803.2010.00475.x

Table 3.

CHD-TAAQOL—Worries, Symptoms, and Impact of Cardiac Surveillance for Whom Patients Reported Distress

Variable n (%)* Mean ± SD
Worries 70.4 ± 18.6
 Current health 45 (83)
 Job/future job 37 (69)
 Working life 33 (61)
 Living independently 29 (54)
 Exertion or sports 26 (48)
 Education 25 (46)
 Relationships 25 (46)
 Having children 25 (46)
 Having friends 24 (44)
 Being home alone 18 (33)
Symptoms 77.4 ± 13.8
 Shortness of breath walking ½ to 3 miles 37 (69)
 Palpitations 33 (61)
 Dizziness 33 (61)
 Nocturia 26 (48)
 Shortness of breath walking < 100 yards 23 (43)
 Edema (ankle, legs, abdomen) 15 (28)
 Looking pale 15 (28)
 Cyanosis during exercising 14 (26)
 Orthopnea 12 (22)
Impact of cardiac surveillance 80 ± 10.3
 Cardiac hospital admission 19 (35)
 Cardiology visit 16 (30)
 Echocardiogram 13 (24)
 Taking blood 13 (24)
 Electrocardiogram 12 (22)
 Chest x-ray 11 (20)
 Flu vaccine 6 (11)
*

Percentages totaled and ranked according to transformed scores ≥3 on a scale of 1–5.

Scale range 0–100; higher scores indicating less symptoms, worries and impact of cardiac surveillance, or better HRQOL.

SD, standard deviation; CHD-TAAQOL, Congenital Heart Disease TNO/AZL Adult Quality Of Life; HRQOL, health-related quality of life.